Additionally, dehydromiltirone (7) improved IBD by regulating the receptor-interacting protein kinases (RIPs)–mixed lineage kinase domain-like protein (MLKL)–caspase-8 axis [102,103]. The gene discussed is MLKL; the disease is inflammatory bowel disease.